US FDA Wants Remote Regulatory Assessment Authority For Cosmetics – FY 2023 Budget Justification
Executive Summary
After freezing its routine inspection activities at the height of the COVID-19 pandemic, the FDA adapted its oversight approach visibly in the drug and medical devices sectors, including with voluntary remote regulatory assessments. The agency now seeks authority to continue that work on a non-voluntary basis across all FDA-regulated programs.
You may also be interested in...
'Could Put Us Out Of Business’: US State Bill Pileup Has Small Beauty Set On Federal Preemption
The cosmetics industry has an “optics” problem, and that is creating other issues, namely a growing body of state legislation to address perceived gaps in federal regulatory oversight.
US FDA Packages Suggestions To Amend DSHEA In Fiscal Year 2023 Budget Request
Biden administration’s FY2023 budget request for FDA includes $1.23bn for food programs, which include regulation of supplement manufacturing and marketing. The funding, an increase of more than $128,000 from FDA’s current food programs budget, would be split between $419,932 for CFSAN and $800,261 for related field work by ORA.
Biden Requests US FDA Budget Surge: Pandemic Preparedness Money Would Increase Funding 36%
President Biden’s budget request would add $1.63bn in mandatory funding to the FDA budget in FY 2023.